Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma

Yutong Chen, Weiran Huang, Jian Ouyang, Jingxiang Wang, Zhengwei XieInternational Journal of Molecular Sciences 2023 · DOI

TL;DR

This study identifies distinct subgroups of liver cancer (HCC) based on anoikis-related genes, revealing one subgroup with poorer survival. They developed a robust prognostic risk model using five key genes that accurately predicts patient survival and is validated across multiple independent datasets, offering potential for improved diagnosis and targeted therapies.

What Problem Does This Paper Address?

Hepatocellular carcinoma (HCC) is a deadly cancer with limited diagnostic tools and a significant need for better prognostic markers. A key characteristic of many cancers, including HCC, is resistance to anoikis – a form of programmed cell death triggered by the loss of cell-matrix adhesion. While this resistance is crucial for tumor survival and metastasis, the specific molecular mechanisms driving anoikis resistance in HCC and its impact on patient prognosis remain poorly understood. This paper aims to bridge this knowledge gap by identifying anoikis-related molecular signatures that can stratify HCC patients and predict their outcomes.

Methods

The researchers employed a multi-pronged bioinformatics approach:

  • Differential Gene Expression Analysis: They first identified genes that were significantly differently expressed in HCC tumor samples compared to normal tissue using data from The Cancer Genome Atlas (TCGA).
  • Anoikis Gene Set Enrichment: They cross-referenced these differentially expressed genes with a curated list of known anoikis-related genes to pinpoint relevant candidates.
  • Unsupervised Clustering: To identify distinct patient subgroups based on these anoikis-related genes, they used consensus clustering, Principal Component Analysis (PCA), t-distributed Stochastic Neighbor Embedding (t-SNE), and Uniform Manifold Approximation and Projection (UMAP).
  • Weighted Gene Coexpression Network Analysis (WGCNA): This technique was used to identify modules of highly correlated genes within the anoikis-related gene set, helping to uncover key biological pathways and identify central genes.
  • Prognostic Model Construction: They built a prognostic risk model using univariate Cox proportional hazards regression, followed by LASSO (Least Absolute Shrinkage and Selection Operator) regression to select the most predictive genes. A risk score was calculated for each patient.
  • Immune Infiltration Analysis: The CIBERSORT algorithm was utilized to quantify the abundance of different immune cell types within tumor samples and to assess their correlation with the identified risk score and prognostic genes.
  • Validation: The developed prognostic model and its associated genes were rigorously validated using independent datasets from the International Cancer Genome Consortium (ICGC) and Gene Expression Omnibus (GEO).

Datasets

  • Training and Discovery: The Cancer Genome Atlas (TCGA) liver hepatocellular carcinoma (LIHC) dataset was used for initial subgroup identification, gene module discovery, and prognostic model development.
  • Validation:
    • International Cancer Genome Consortium (ICGC) Liver Cancer-RIKEN, JP (LIRI-JP) cohort.
  • Gene Expression Omnibus (GEO) datasets: GSE84402 and GSE101685.
  • Gene Information: Anoikis-related genes were acquired from GeneCards.

Key Insights and Ideas

  • Anoikis Resistance as a Driver of HCC Subtypes: The study strongly suggests that variations in anoikis resistance mechanisms are not just a general cancer trait but can define distinct molecular subtypes within HCC, impacting patient survival.
  • The "Barrier" Against Anoikis is Not Uniform: The identification of two distinct subgroups (A and B) with significantly different survival probabilities highlights that HCC tumors don't all evade anoikis in the same way, implying different underlying molecular vulnerabilities or strengths.
  • A Core Set of Five Genes Dictates Prognosis: The discovery of five specific anoikis-related genes (BAK1, SPP1, BSG, PBK, and DAP3) that consistently predict survival across multiple datasets is a significant finding, offering concrete targets for diagnostic and therapeutic development.
  • Immune Microenvironment is Intertwined with Anoikis Resistance: The strong correlation between the prognostic risk score, individual prognostic genes, and immune cell infiltration suggests that the tumor's ability to resist anoikis is closely linked to the immune cells present in its microenvironment. This opens avenues for immunotherapy strategies.

Key Results

  • Two Anoikis-Related Subgroups Identified: TCGA-LIHC samples were successfully divided into two subgroups (A and B), with subgroup A exhibiting significantly lower overall survival (p = 0.00012).
  • Five Prognostic Genes Identified: BAK1, SPP1, BSG, PBK, and DAP3 were identified as key anoikis-related genes that significantly predict overall survival.
  • Robust Prognostic Risk Model: A risk score model based on these five genes demonstrated strong predictive performance for overall survival in the training dataset (AUCs at 1, 3, and 5 years: 0.796, 0.727, and 0.826, respectively).
  • External Validation: The prognostic model's effectiveness was confirmed in independent ICGC and GEO datasets, showing consistent performance in predicting survival and gene expression patterns.
  • Correlation with Immune Infiltration: The risk score showed significant positive correlations with several immune cell types, including monocytes and macrophages, and negative correlations with eosinophils and resting mast cells. The prognostic genes also showed strong correlations with most immune cells.

Limitations and Future Work

  • Limited Cohort Size and Clinical Data: The authors acknowledge that the number of cohorts and the available clinicopathological data were limited, suggesting that more comprehensive datasets are needed for more precise survival prediction.
  • Need for Basic Experimental Validation: The study relied heavily on bioinformatics analysis. The authors explicitly state the need for basic laboratory experiments to validate the expression of the identified prognostic genes in liver cancer cell lines.
  • Further Mechanistic Studies: While the study identifies correlations, deeper investigation into the precise molecular mechanisms by which these five genes contribute to anoikis resistance and influence the immune microenvironment in HCC is warranted.
  • Therapeutic Implications: The findings suggest potential for targeted therapies and immunotherapies, which would require further preclinical and clinical investigation.

Summary updated

Abstract

Resistance to anoikis is a key characteristic of many cancer cells, promoting cell survival. However, the mechanism of anoikis in hepatocellular carcinoma (HCC) remains unknown. In this study, we applied differentially expressed overlapping anoikis-related genes to classify The Cancer Genome Atlas (TCGA) samples using an unsupervised cluster algorithm. Then, we employed weighted gene coexpression network analysis (WGCNA) to identify highly correlated genes and constructed a prognostic risk model based on univariate Cox proportional hazards regression. This model was validated using external datasets from the International Cancer Genome Consortium (ICGC) and Gene Expression Omnibus (GEO). Finally, we used a CIBERSORT algorithm to investigate the correlation between risk score and immune infiltration. Our results showed that the TCGA cohorts could be divided into two subgroups, with subgroup A having a lower survival probability. Five genes (<i>BAK1</i>, <i>SPP1</i>, <i>BSG</i>, <i>PBK</i> and DAP3) were identified as anoikis-related prognostic genes. Moreover, the prognostic risk model effectively predicted overall survival, which was validated using ICGC and GEO datasets. In addition, there was a strong correlation between infiltrating immune cells and prognostic genes and risk score. In conclusion, we identified anoikis-related subgroups and prognostic genes in HCC, which could be significant for understanding the molecular mechanisms and treatment of HCC.
BibTeX
@article{chen2023identification,
  author = {Yutong Chen and Weiran Huang and Jian Ouyang and Jingxiang Wang and Zhengwei Xie},
  title = {{Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma}},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032862},
}
Figure